The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Bile acid metabolites control TH17 and Treg cell differentiation
Open accessPublished version of a preprint
Abstract
Bile acids are abundant in the mammalian gut, where they undergo bacteria-mediated transformation to generate a large pool of bioactive molecules. Although bile acids are known to affect host metabolism, cancer progression and innate immunity, it is unknown whether they affect adaptive immune cells such as T helper cells that express IL-17a (T H 17 cells) or regulatory T cells (T reg cells). Here we screen a library of bile acid metabolites and identify two distinct derivatives of lithocholic acid (LCA), 3-oxoLCA and isoalloLCA, as T cell regulators in mice. 3-OxoLCA inhibited the differentiation of T H 17 cells by directly binding to the key transcription factor retinoid-related orphan receptor-γt (RORγt) and isoalloLCA increased the differentiation of T reg cells through the production of mitochondrial reactive oxygen species (mitoROS), which led to increased expression of FOXP3. The isoalloLCA-mediated enhancement of T reg cell differentiation required an intronic Foxp3 enhancer, the conserved noncoding sequence (CNS) 3; this represents a mode of action distinct from that of previously identified metabolites that increase T reg cell differentiation, which require CNS1. The administration of 3-oxoLCA and isoalloLCA to mice reduced T H 17 cell differentiation and increased T reg cell differentiation, respectively, in the intestinal lamina propria. Our data suggest mechanisms through which bile acid metabolites control host immune responses, by directly modulating the balance of T H 17 and T reg cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, it is noteworthy that certain secondary BAs serve significant biological functions, including the regulation of host metabolism, immunity, and resistance against intestinal pathogen expansion.21,360–364”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [363]
In the citing paper
“On the other hand, certain secondary BAs exert anti-inflammatory effects by stimulating Treg cell differentiation and inhibiting TH17 cell differentiation.361,363,364,702,710”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [363]
In the citing paper
“Hence, in humans BACH2 might be an important regulator of homeostatic Th17 cells that could be exploited for the treatment of human autoimmune diseases.”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [60]
In the citing paper
“multiple single-nucleotide polymorphisms (SNPs) in the BACH2 locus are associated with human autoimmune diseases and a protective allele for MS disease correlates with an increase of BACH2 expression in CD4+ T cells”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [60]
In the citing paper
“by integrating single-cell ATAC-seq and single-cell RNA-seq, we generated a regulatory network across npTh17, pTh17, and Th1 cells”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [60]
In the citing paper
“Predicted regulators of the non-pathogenic- and general- Th17 program included RORγt, ETS1, BACH2, FOSL2, and RBPJ.”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [60]
In the citing paper
“The network predicted the pathogenic Th17- and Th1- program to be regulated by the transcription factors ATF3, BHLHE40, FOS, NR4A1, EOMES, and T-BET.”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [60]
In the citing paper
“We validated BACH2 as a novel regulator of Th17 pathogenicity that promoted immunomodulatory programs and restrained pro-inflammatory Th1-like programs in Th17 cells.”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698
Bokulich, N. A., Kaehler, B. D., Rideout, J. R., Dillon, M. R., Bolyen, E. K., Knight, R. D., Huttley, G. A., & Caporaso, J. G. (2018) · Microbiome · doi:10.1186/s40168-018-0470-z · Cited by 6,037
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
Self-citationBile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508
Sena, L. A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D. A., Wang, C.-R., Schumacker, P. T., Licht, J. D., Perlman, H., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.020 · Cited by 1,338
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil‐de‐Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,304
T cell metabolism drives immunity
Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151159 · Cited by 1,238
Cited by
Sorted by citations
Items 601–700 of 999
The alternative bile acid pathway can predict food allergy persistence in early childhood
Lee, S., Park, Y. M., Yoo, H. J., Lee, S., Choi, E. J., Paek, E. Y., Song, K. B., Yoon, J., & Hong, S. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.14003 · Cited by 18
TGF‐β1 signaling and Smad7 control T‐cell responses in health and immune‐mediated disorders
Laudisi, F., Stolfi, C., Monteleone, I., & Monteleone, G. (2023) · European Journal of Immunology · doi:10.1002/eji.202350460 · Cited by 22
Cui, H., Lian, J., Xu, B., Yu, Z., Xiang, H., Shi, J., Gao, Y., & Han, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-46805-6 · Cited by 19
Bile acids and bile acid activated receptors in the treatment of Covid-19
Fiorucci, S., Urbani, G., Biagioli, M., Sepe, V., Distrutti, E., & Zampella, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115983 · Cited by 18
Tzeng, H., & Lee, W.-C. (2024) · Nutrients · doi:10.3390/nu16091388 · Cited by 18
Zhang, M., Dang, M., Wu, X., Li, O., Li, M., Zhao, C., Wei, P.-F., Dong, T., Li, Y., & Wu, C. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118275 · Cited by 22
Taming the Sentinels: Microbiome-Derived Metabolites and Polarization of T Cells
Wojciech, Ł., Tan, K. S. W., & Gascoigne, N. R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207740 · Cited by 19
A Triple Threat? The Role of Diet, Nutrition, and the Microbiota in T1D Pathogenesis
Hamilton‐Williams, E. E., Lorca, G. L., Norris, J. M., & Dunne, J. L. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.600756 · Cited by 20
Gregor, A., Pignitter, M., Fahrngruber, C., Bayer, S., Somoza, V., König, J. S., & Duszka, K. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108781 · Cited by 19
Network Biology Approaches to Achieve Precision Medicine in Inflammatory Bowel Disease
Thomas, J. P., Módos, D., Korcsmáros, T., & Brooks-Warburton, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.760501 · Cited by 21
Regulation of immune responses to food by commensal microbes
Light, S. H., & Nagler‐Anderson, C. (2024) · Immunological Reviews · doi:10.1111/imr.13396 · Cited by 18
Li, Z., Deng, L., Cheng, M., Ye, X., Yang, N., Fan, Z., & Sun, L. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5730 · Cited by 20
Role of regulatory T cells in inflammatory liver diseases
Yang, L., & Zheng, S. G. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103806 · Cited by 17
Nutrient acquisition of gut microbiota: Implications for tumor immunity
Wang, Y., Huang, J., Tong, H., Jiang, Y., Yu, J., & Ma, X. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.003 · Cited by 19
Jugder, B., Park, E., Du, L., Jawale, C. V., Popov, N., Guo, Z., Bednar, K. J., & Ort, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1650451 · Cited by 18
The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites
Lu, D., Zou, X., & Zhang, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.948755 · Cited by 20
Microbial Components and Effector Molecules in T Helper Cell Differentiation and Function
Lee, C., Lee, H., Park, J. C., & Im, S. (2023) · Immune Network · doi:10.4110/in.2023.23.e7 · Cited by 19
Metabolic Bile Acid Profile Impairments in Dogs Affected by Chronic Inflammatory Enteropathy
Comito, R., Porru, E., Interino, N., Conti, M., Terragni, R., Gotti, R., Candela, M., Simoni, P., Roda, A., & Fiori, J. (2023) · Metabolites · doi:10.3390/metabo13090980 · Cited by 22
Lu, Z., Hsu, C., Younis, N. K., Mustafa, M. A., Matveeva, E. A., Al-Juboory, Y. H. O., Adil, M., Athab, Z. H., & Abdulraheem, M. N. (2024) · Apmis · doi:10.1111/apm.13401 · Cited by 19
Anti-fungal T cell responses in the lung and modulation by the gut-lung axis
Scheffold, A., & Bächer, P. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.06.006 · Cited by 18
Interkingdom Communication and Regulation of Mucosal Immunity by the Microbiome
Ethridge, A. D., Bazzi, M., Lukacs, N. W., & Huffnagle, G. B. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa748 · Cited by 20
Nguyen, C. L., Docampo, M. D., van den Brink, M. R. M., & Markey, K. A. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.11.007 · Cited by 17
Human Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 28
Lin, Z., Dai, W., Hu, S., Chen, D., Yan, H., Zeng, L., & Lin, Z. (2024) · Food & Function · doi:10.1039/d3fo05176e · Cited by 17
Sun, L. Y., Yang, N., Liu, Z., Ye, X., Cheng, M., Deng, L., Zhang, J., Wu, J., Shi, M., & Liao, W. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01052-3 · Cited by 19
Xu, J., Li, J., Xue, G., Huang, C.-T., Peng, Y., Xu, H., Li, Y., Xu, J., Hu, J., Liao, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202509073 · Cited by 23
The gut–lung axis in asthma: microbiota-driven mechanisms and therapeutic perspectives
Yang, Z., Mao, W., Wang, J., & Yin, L. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1680521 · Cited by 21
Wu, G., Wang, R., Wang, Y., Sun, S., Chen, J., & Zhang, Q. (2025) · Foods · doi:10.3390/foods14223836 · Cited by 17
Microbiome-derived bile acid signatures in early life and their association with islet autoimmunity
Lamichhane, S., Dickens, A. M., Buchacher, T., Lou, T., Charron‐Lamoureux, V., Kattelus, R., Karmacharya, P., da Silva, L. P., Kråkström, M., Rasool, O., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66619-6 · Cited by 18
Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omics
de Saedeleer, B., Malabirade, A., Ramiro‐Garcia, J., Habier, J., Trezzi, J., Peters, S. L., Daujeumont, A., Halder, R., Jäger, C., Busi, S. B., et al. (2021) · ISME Communications · doi:10.1038/s43705-021-00078-0 · Cited by 17
New Kids on the Block: Bile Salt Conjugates of Microbial Origin
Ay, Ü., Leníček, M., Claßen, A., Damink, S. W. M. O., Bolm, C., & Schaap, F. G. (2022) · Metabolites · doi:10.3390/metabo12020176 · Cited by 18
Kou, K., Sun, X., Tian, G., Yao, Z., Fan, Z., & Lv, G. (2022) · Journal of Immunology Research · doi:10.1155/2022/5091275 · Cited by 17
Simpkins, D., Downton, P. J., Gray, K. J., Dickson, S. H., Maidstone, R. J., Konkel, J. E., Hepworth, M. R., Ray, D. W., Bechtold, D. A., & Gibbs, J. E. (2022) · The FASEB Journal · doi:10.1096/fj.202201728r · Cited by 16
Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus
Cui, K., Yang, W., Liu, Z., Liu, G., Li, D., Sun, Y., He, G., Ma, S., Cao, Y., Jiang, X., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02430-22 · Cited by 17
Wang, J., Zhang, X., Yang, X., Yu, H., Bu, M.-M., Fu, J., Zhang, Z., Xu, H., Hu, J., Lu, J., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1191936 · Cited by 18
Self-citationBMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy
Wang, S., Xu, N., Wang, J., Chen, Y., Li, W., Chen, H., Shen, C., Xu, C., Wei, X., Lu, D., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216336 · Cited by 17
Kumar, S. S., Fathima, A., Srihari, P., & Trinath, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1392565 · Cited by 17
Self-citationShi, G., Chang, Z., Zhang, P., Zou, X., Zheng, X., Liu, X., Yan, J., Xu, H., Tian, Z., Zhang, N., et al. (2024) · Cell Proliferation · doi:10.1111/cpr.13715 · Cited by 17
Liu, Y., Wang, Y., Ren, T., Yu, G., Meng, X., Feng, L., Li, F. R., Zhang, J., & Wang, C. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176858 · Cited by 17
van Lier, Y. F., van den Brink, M. R. M., Hazenberg, M. D., & Markey, K. A. (2021) · Haematologica · doi:10.3324/haematol.2020.270835 · Cited by 18
Weber, M. G., Walters-Laird, C. J., Kol, A., Rocha, C. S., Hirao, L. A., Mende, A., Balan, B., Arredondo, J., Elizaldi, S. R., Iyer, S. S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.149033 · Cited by 17
O’Mahony, C., Clooney, A. G., Clarke, S. F., Aguilera, M., Gavin, A. M., Simnica, D., Ahern, M., Fanning, A., Stanley, M., Cabrera‐Rubio, R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031864 · Cited by 18
Therapeutics Targeting the Gut Microbiome: Rigorous Pipelines for Drug Development
Markey, K. A., van den Brink, M. R. M., & Peled, J. U. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.022 · Cited by 16
What's eating you? An update on Giardia, the microbiome and the immune response
Singer, S. M., Angelova, V. V., DeLeon, H., & Miskovsky, E. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.09.006 · Cited by 17
New drug therapies for metabolic dysfunction-associated steatohepatitis
Chiang, J. Y. L. (2025) · Liver Research · doi:10.1016/j.livres.2025.01.001 · Cited by 18
Allo-lithocholic acid, a microbiome derived secondary bile acid, attenuates liver fibrosis
Marchianò, S., Biagioli, M., Giorgio, C. D., Massa, C., Bellini, R., Bordoni, M., Urbani, G., Lachi, G., Sepe, V., Morretta, E., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116883 · Cited by 18
Gut-Microbiota-Driven Lipid Metabolism: Mechanisms and Applications in Swine Production
Xiong, S. (2025) · Metabolites · doi:10.3390/metabo15040248 · Cited by 16
Health benefits of medicinal plant natural products via microbiota-mediated different gut axes
Li, X., Liu, Y., Liu, N., Wu, H., Cong, K., Duan, L., Chen, T., & Zhang, J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107730 · Cited by 17
Liu, Q., Hua, Y., He, R., Xiang, L., Li, Y., Zhang, Y., Chen, R., Li, Q., Jiang, X., Wang, C., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102130 · Cited by 16
Lithocholic acid promotes rosacea-like skin inflammation via G protein-coupled bile acid receptor 1
Xiao, W., Chen, M., Peng, Q., Sha, K., Liu, T., Xia, J., Xie, H., Li, J., Xu, S., & Deng, Z. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166563 · Cited by 16
Liu, S., Wen, D., Feng, C., Yu, C., Gu, Z., Wang, L., Zhang, Z., Li, W., Wu, S., Liu, Y., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1114233 · Cited by 18
Koshida, K., Ito, M., Yakabe, K., Takahashi, Y., Tai, Y., Akasako, R., Kimizuka, T., Takano, S., Sakamoto, N., Haniuda, K., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108549 · Cited by 16
Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity
Zhong, G., He, C., Wang, S., Lin, C., & Li, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1241262 · Cited by 17
Cheng, W., Zhou, X., Jin, C., Wu, J., Yi, X., Lu, M., Yang, Y., Jin, X., Ji, F., & Wang, B. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.039 · Cited by 16
Exploring the complex interplay: gut microbiome, stress, and leptospirosis
Petakh, P., Oksenych, V., Kamyshna, I. I., Boisak, I., Lyubomirskaya, K., & Kamyshnyi, O. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1345684 · Cited by 16
Zhuo, L., Yang, Y., Xiao, C., Li, F., Lin, L., Xi, Y., Fu, Y., Zheng, J., & Chen, Y. (2024) · Food & Function · doi:10.1039/d4fo00961d · Cited by 17
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Méndez‐Sánchez, N., Brouwer, W. P., Lammert, F., & Yilmaz, Y. N. (2024) · Hepatology International · doi:10.1007/s12072-024-10662-w · Cited by 16
Biological functions and pharmacological behaviors of bile acids in metabolic diseases
Zhuang, T., Wang, X., Wang, Z., Gu, L., Yue, D., Wang, Z., Li, X., Yang, L., Huang, W., & Ding, L. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.11.003 · Cited by 23
Gut microbiome composition and metabolic activity in metabolic-associated fatty liver disease
Zhang, D., Wang, Q., Li, D., Chen, S., Chen, J., Zhu, X., & Bai, F. (2025) · Virulence · doi:10.1080/21505594.2025.2482158 · Cited by 16
Immunological Impact of Intestinal T Cells on Metabolic Diseases
Zhou, H., Wang, L., & Liu, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639902 · Cited by 19
Informal nutrition symposium: leveraging the microbiome (and the metabolome) for poultry production
Lee, M. D., Ipharraguerre, I. R., Arsenault, R. J., Lyte, M., Lyte, J. M., Humphrey, B. D., Angel, R., & Korver, D. R. (2021) · Poultry Science · doi:10.1016/j.psj.2021.101588 · Cited by 16
Chemoproteomic Analysis of Microbiota Metabolite–Protein Targets and Mechanisms
Zhao, X., Yang, X., & Hang, H. C. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00758 · Cited by 16
Targeting regulatory T cell metabolism in disease: Novel therapeutic opportunities
Halvorson, T., Tuomela, K., & Levings, M. K. (2023) · European Journal of Immunology · doi:10.1002/eji.202250002 · Cited by 18
Xiong, Y., Ma, X., He, B., Zhi, J., Liu, X., Wang, P., Zhou, Z., & Liu, D. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c09682 · Cited by 15
Dong, Y., Zhang, L., Qiu, D., Yao, R., Jia, H., Wang, H., Zhou, L., Zhang, J., & Zhang, N. (2025) · Foods · doi:10.3390/foods14081416 · Cited by 15
Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases
Saha, P., & Hartmann, P. (2025) · Microorganisms · doi:10.3390/microorganisms13061188 · Cited by 16
Bile acid modulation of host immunity
Anh, N. B., Yang, X., & Hang, H. C. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.70014 · Cited by 16
Psoriasis and gut microbes: research advances from mechanism to therapy
Chen, J., Sun, K., Zhang, X., Chen, X., Chu, Y., Geng, L., Bian, Z., Su, Y., Cong, X., & Wang, G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1711288 · Cited by 16
Gut microbiome in liver pathophysiology and cholestatic liver disease
Yan, S., & Yin, X. (2021) · Liver Research · doi:10.1016/j.livres.2021.08.001 · Cited by 16
Mutual interaction of microbiota and host immunity during health and diseases
Wu, D., Zhang, Y., Dong, S., & Zhong, C. (2021) · Biophysics Reports · doi:10.52601/bpr.2021.200045 · Cited by 16
Changes of intestinal microbiota and microbiota-based treatments in IBD
Li, Q., Zhou, S., Wang, Y., & Cong, J. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03069-4 · Cited by 16
Autoantibodies in Primary Biliary Cholangitis
Leung, K. K., & Hirschfield, G. M. (2022) · Clinics in Liver Disease · doi:10.1016/j.cld.2022.06.004 · Cited by 15
Chen, Y., Wang, Z., Chen, X., Chao, G., & Zhang, S. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad032 · Cited by 16
Taurodeoxycholate ameliorates DSS-induced colitis in mice
Zou, Y., Ghaderpour, A., Munkhbileg, B., Seo, S., & Seong, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110628 · Cited by 15
Gao, T., Hu, S., Xu, W., Wang, Z., Guo, T., Chen, F., Ma, Y., Zhu, L., Chen, F., Wang, X., et al. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-05017-7 · Cited by 15
Lin, K., Zheng, W., Guo, M., Zhou, R., Zhang, M., & Liu, T. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167089 · Cited by 17
Myszor, I. T., Lapka, K., Hermannsson, K., Rekha, R., Bergman, P., & Gudmundsson, G. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-57251-3 · Cited by 12
Enteropathway: the metabolic pathway database for the human gut microbiota
Shiroma, H., Darzi, Y., Terajima, E., Nakagawa, Z., Tsuchikura, H., Tsukuda, N., Moriya, Y., Okuda, S., Goto, S., & Yamada, T. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae419 · Cited by 17
Pediatric migraine is characterized by traits of ecological and metabolic dysbiosis and inflammation
Papetti, L., CHIERICO, F. D., Frattale, I., Toto, F., Scanu, M., Mortera, S. L., Rapisarda, F., Michele, M. D., Monte, G., Ursitti, F., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01871-7 · Cited by 14
Yadav, B., Specht, C. A., Lee, C. K., Pokrovskii, M. V., Huh, J. R., Littman, D. R., & Levitz, S. M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009891 · Cited by 15
Self-citationSupplemental Leuconostoc mesenteroides strain NTM048 attenuates imiquimod‐induced psoriasis in mice
Ogawa, C., Inoüe, R., Yonejima, Y., Hisa, K., Yamamoto, Y., & Suzuki, T. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15161 · Cited by 15
Tao, Z., Luo, Z., Zou, Z., Ye, W., Hao, Y., Li, X., Zheng, K., Wu, J., Xia, J., Zhao, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1580369 · Cited by 14
Zhou, Z., Lv, Y., Zuo, A., Zhu, X., Xu, Y., Zuo, L., Xu, H., Liu, S., Zhang, Y., Weng, S., et al. (2025) · hLife · doi:10.1016/j.hlife.2025.05.008 · Cited by 15
Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome
Dutta, B., Tripathy, A., Archana, P. R., & Kamath, S. U. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01837-y · Cited by 19
Villette, R., Sunyer, J. O., Novikova, P. V., Aho, V. T. E., Петров, В. А., Hickl, O., Busi, S. B., Rudder, C. D., Kunath, B. J., Heintz‐Buschart, A., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02227-2 · Cited by 17
Zhou, H., Huang, Y., Chen, C., Song, M., & Hylemon, P. B. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100120 · Cited by 17
Microbial metabolites in tumor epigenetic regulation
Zhang, W., Zhang, H., Liao, Y., Jiang, S., Zhang, H., Huang, C., Song, Z., Zhao, R., Lü, P., Kang, X., et al. (2026) · iMeta · doi:10.1002/imt2.70115 · Cited by 17
Reciprocal Interactions Between Regulatory T Cells and Intestinal Epithelial Cells
Jiang, Z., & Wu, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951339 · Cited by 16
Liang, B., Wu, C., Wang, C., Sun, W., Chen, W., Hu, X., Liu, N., & Xing, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1065608 · Cited by 15
González-Brito, A., & Uribe‐Herranz, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1083303 · Cited by 14
Zhang, H., Xia, N., Tang, T., Nie, S., Zha, L., Zhang, M., Lv, B., Lu, Y., Jiao, J., Li, J., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03896-z · Cited by 14
The molecular insights of bile acid homeostasis in host diseases
Zhang, J., Lü, A., & Wang, C. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121919 · Cited by 15
Targeting gut microbiota for immunotherapy of diseases
Yu, Y., Liu, X., Liao, C., Yu, R., Wang, X., Li, M., & Wang, Y. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03770-x · Cited by 14
Dietary patterns interfere with gut microbiota to combat obesity
Lou, X., Li, P., Luo, X., Lei, Z., Liu, X., Liu, Y., Gao, L., Xu, W., & Liu, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1387394 · Cited by 20
Xie, W., Sharma, A., Kaushik, H. K., Sharma, L., Nistha, Anwer, M. K., Sachdeva, M., Elossaily, G. M., Zhang, Y., Pillappan, R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35336 · Cited by 14
Virkud, Y. V., Styles, J. N., Kelly, R. S., Patil, S. U., Ruiter, B., Smith, N. P., Clish, C. B., Wheelock, C. E., Celedon, J. C., Litonjua, A. A., et al. (2024) · Pediatric Allergy and Immunology · doi:10.1111/pai.14267 · Cited by 19
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights
Moutsoglou, D., Ramakrishnan, P., & Vaughn, B. P. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2477255 · Cited by 14
Zhai, T., Zou, X., Zhang, Z., Wang, Y., Shi, L. S., Ren, W., & Huang, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2532703 · Cited by 17
Bile Acids Impair Vaccine Response in Children With Biliary Atresia
Liu, J., Fei, Y., Zhou, T., Ji, H., Wu, J. Y., Gu, X., Luo, Y., Zhu, J., Feng, M., Wan, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642546 · Cited by 13
Li, W., Wang, X., Zhang, X., Gong, P., Ding, D., Wang, N., & Wang, Z. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01572-z · Cited by 14
Metadata
- Authors
- Hang, S., Paik, D., Yao, L., Kim, E., Trinath, J., Lu, J., Ha, S., Nelson, B. N., Kelly, S. P., Wu, L., Zheng, Y., Longman, R. S., Rastinejad, F., Devlin, A. S., Krout, M. R., Fischbach, M. A., Littman, D. R., & Huh, J. R.
- Affiliations
- Harvard University (US)
- Birla Institute of Technology and Science - Hyderabad Campus (IN)
- Bucknell University (US)
- New York University (US)
- Salk Institute for Biological Studies (US)
- Weill Cornell Medicine (US)
- University of Oxford (GB)
- Stanford University (US)
- Howard Hughes Medical Institute (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Fischbach, Michael A.
- Littman, Dan R.
- Huh, Jun R.
- ORCID
- Venue
- Nature
- Published
- 2019-11-27
- Volume
- 576
- Issue
- 7785
- Pages
- 143-148
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6949019
- OpenAlex
- W2990182987
- Cited by
- 1,457
- References
- 59
- Citations by year
- 2026: 274 · 2025: 287 · 2024: 260 · 2023: 207 · 2022: 174 · 2021: 158 · 2020: 94 · 2019: 3
- FWCI
- 43.07
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-02-25)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- Wellcome Trust (210664/Z/18/Z)
- National Institute of Allergy and Infectious Diseases (R01AI107027, R01AI080885)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK103358, R01DK114252, R01DK110559, P30DK034854)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- bile acid metabolites, lithocholic acid, Th17 cell differentiation, regulatory T cells, RORγt, Foxp3, mitochondrial reactive oxygen species, gut microbiota, intestinal lamina propria, IL-17A, T cell regulation
- MeSH terms
- Animals, Cell Differentiation, Lithocholic Acid, Mice, Inbred C57BL, Reactive Oxygen Species, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
